Skip to main content

Year: 2019

Dassault Aviation : Nombre total actions et droits de vote au 30 11 2019

DASSAULT AVIATIONSociété anonyme au capital de 66 789 624 eurosSiège social : 9, Rond-Point des Champs-Elysées Marcel Dassault75008 PARISRCS PARIS 712 042 456Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L. 233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés FinanciersPièce jointeNombre total actions et droits de vote au 30 11 2019

Continue reading

TM publishes prospectus

TM hf. publishes prospectus in connection with:Application for new shares to be accepted for trading on the Nasdaq Iceland Main MarketPriority rights offer and general offer for 93,750,000 new shares in TMThe total number of shares issued in TM hf. (“TM”) is 678,142,669. The company intends to issue an additional 93,750,000 new shares. Each share is ISK 1 nominal price, and the shares have been issued in accordance with Icelandic law. Trading with the new shares will be in the systems of Nasdaq Iceland under the identifier TM (ISIN: IS0000000586).Both the priority rights offer and the general offer are subject to the rules of Act No. 108/2007 on Securities Transactions as regards general offers. In this advertisement, the term “offer” is used as a synonym for both offer forms.Offer 9–12 DecemberTM hf. plans to sell new shares in the share...

Continue reading

TM birtir lýsingu

TM hf. birtir lýsingu í tengslum við:Umsókn um að ný hlutabréf verði tekin til viðskipta á Aðalmarkaði Nasdaq IcelandForgangsréttarútboð og almennt útboð á 93.750.000 nýjum hlutum í TMHeildarfjöldi útgefinna hluta í TM hf. (“TM”) er 678.142.669 og hyggst félagið gefa út 93.750.000 nýja hluti til viðbótar. Hver hlutur er 1 króna að nafnverði og hafa hlutirnir verið gefnir út í samræmi við íslensk lög. Viðskipti með hina nýju hluti verða í kerfum Nasdaq Iceland undir auðkenninu TM (ISIN: IS0000000586).Bæði forgangsréttarútboðið og almenna útboðið lúta reglum laga nr. 108/2007 um verðbréfaviðskipti varðandi almenn útboð. Í auglýsingu þessari er  hugtakið “útboð”  notað sem samheiti um útboðin tvö.Útboð 9.-12. desemberTM hf. hyggst selja nýja hluti í útboðinu. Markmið útboðsins er fjármögnun á kaupum TM á öllu hlutafé Lykils fjármögnunar...

Continue reading

Albion Venture Capital Trust PLC: Half-yearly Financial Report

Albion Venture Capital Trust PLCLEI Code: 213800JKELS32V2OK421As required by the UK Listing Authority’s Disclosure Guidance and Transparency Rule 4.2, Albion Venture Capital Trust PLC today makes public its information relating to the Half-yearly Financial Report (which is unaudited) for the six months to 30 September 2019. This announcement was approved by the Board of Directors on 4 December 2019.The full Half-yearly Financial Report (which is unaudited) for the period to 30 September 2019 will shortly be sent to shareholders and will be available on the Albion Capital Group LLP website by clicking www.albion.capital/funds/AAVC/30Sep2019.pdf.Investment policyAlbion Venture Capital Trust PLC (the “Company”) is a venture capital trust and the investment policy is intended to produce a regular and predictable dividend stream with an...

Continue reading

ALSTOM SA: Disclosure of the total number of voting rights and shares forming the share capital as at 30 November 2019

 4 December 2019Disclosure of the total number of voting rights and sharesforming the share capital as at 30 November 2019Information pursuant to article L. 233-8 II of the Code de commerce and articles 223-16 and 223-11 of the AMF General regulation (Règlement général de l’Autorité des marchés financiers)   Attachment2019.11.30 ALSTOM monthly dec

Continue reading

ALSTOM SA : Déclaration du nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2019

4 décembre 2019Déclaration du nombre total de droits de vote et d’actionscomposant le capital social au 30 novembre 2019Information prévue par l’article L. 233-8 II du Code de commerce et des articles 223-16 et 223-11 du Règlement général de l’Autorité des marchés financiers :   Pièce jointe2019.11.30 ALSTOM decl mensuelle

Continue reading

EAB Acquires Leading Interactive Content Provider YouVisit

Washington, DC, Dec. 04, 2019 (GLOBE NEWSWIRE) — Education firm EAB has acquired YouVisit, the leading provider of virtual tour and interactive web content for higher education. The addition of YouVisit’s technology platform, together with its expertise in immersive content creation, further enhances EAB’s ability to help colleges and universities find, engage, and enroll new students.“A college’s website is one of its most important recruiting channels, yet too few provide the dynamic content and tools prospective students are craving to understand a school’s unique value proposition,” said EAB Chief Executive Officer David Felsenthal. “EAB’s acquisition of YouVisit gives our partner schools an unparalleled ability to transform their entire online presence into a competitive differentiator that generates meaningful increases in engagement...

Continue reading

Auction details treasury bills

Auction date December 11, 2019                     Settlement date December 13, 2019Bids have to be entered by 11.00 on December 11, 2019Bid only through dealers approved by the Swedish National Debt OfficeFor more information, please contact: The funding desk+ 46 8 613 4780Fo@riksgalden.se

Continue reading

Nemaura Medical Announces 1 for 10 Reverse Split Intended to Attract a Wider Universe of Institutional Investors

Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) —  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced plans to conduct reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share on a one 1 for 10 basis.  The reverse split is expected to take effect at the market open on December 5, 2019. The new CUSIP number will be 640442208.In accordance with the reverse split, each stockholder’s percentage ownership interest in Nemaura Medical remains unchanged. Any fractional shares resulting from the reverse stock split were rounded up to the nearest whole share of common stock. As a result,...

Continue reading

Nasdaq CEO Adena Friedman to Present at Goldman Sachs U.S. Financial Services Conference 2019

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) —About NasdaqNasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.Media Relations Contacts:Allan Schoenberg(212) 231-5534allan.schoenberg@nasdaq.comWill Briganti(678) 504-6097william.briganti@nasdaq.comInvestor Relations Contact:Ed Ditmire, CFA(212) 401-8737ed.ditmire@nasdaq.com-NDAQF- 

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.